Showing results (781-790 of 4,558) with videos related to

Sort By:
Pageof 456
Neuropsychiatric Disease and Treatment|February 18, 2022
Reduced Peripheral Nerve Conduction Velocity is Associated with Alzheimer's Disease: A Cross-Sectional Study from ChinaXinyi Qian, Ling Yue, David Mellor, et al.
Neuropsychiatric Disease and Treatment|February 21, 2022
Relationship Between Sleep Duration and Stroke History in Middle-Aged and Elderly in Guiyang: A Cross-Sectional SurveyLi Liu, Jingyuan Yang, Junhua Wang, et al.
Neuropsychiatric Disease and Treatment|February 25, 2022
Victimization in Childhood Influences Presenteeism in Adulthood via Mediation by Neuroticism and Perceived Job StressorsShogo Hashimoto, Masahiko Ichiki, Yoshitaka Ishii, et al.
Neuropsychiatric Disease and Treatment|February 25, 2022
Validation of the Chinese Version of the Autism Diagnostic Interview-Revised in Autism Spectrum DisorderChi-Fen Huang, Yu-Siou Lin, Yen-Nan Chiu, et al.
Neuropsychiatric Disease and Treatment|August 22, 2018
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive-compulsive disorderHesam Hasanpour, Ramak Ghavamizadeh Meibodi, Keivan Navi, et al.
Neuropsychiatric Disease and Treatment|May 2, 2019
Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature reviewHai-Yang Wang, Tian Li, Xue-Lin Li, et al.
Neuropsychiatric Disease and Treatment|May 2, 2019
Lifetime predictors of stroke in subjects without a diagnosis of hypertension: the aerobics center longitudinal studyIván Cavero-Redondo, Xuemei Sui, Steven N Blair, et al.
Neuropsychiatric Disease and Treatment|October 16, 2018
The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysisThelma Beatriz González-Castro, Yazmín Hernández-Díaz, Isela Esther Juárez-Rojop, et al.
Neuropsychiatric Disease and Treatment|October 16, 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Kazuto Oya, Yuki Matsui, et al.
Neuropsychiatric Disease and Treatment|October 17, 2018
Construct validity and reliability of the Tachikawa Resilience Scale in the Japan Ground Self-Defense Force personnelTaku Saito, Masanori Nagamine, Jun Shigemura, et al.
Pageof 456